English
Home > Products > Tirzepatide intermediate

China Tirzepatide intermediate Factory

We depend on sturdy technical force and continually create sophisticated technologies to satisfy the demand of Tirzepatide intermediate,CAS NO 2460751-66-8,2460751-66-8,Tirzepatide advance intermediate,Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-OH, Our skilled complex workforce is going to be wholeheartedly at your assistance. We sincerely welcome you to definitely pay a visit to our site and firm and deliver us your inquiry.
Tirzepatide intermediate, Our objects have national accreditation requirements for qualified, high quality products and solutions, affordable value, was welcomed by people today all over the world. Our goods will continue to enhance within the order and look forward to cooperation with you, Need to any of those goods be of interest to you, be sure to letus know. We've been gonna be content to offer you a quotation up on receipt of your detailed needs.

Related Products

Hot Products

  • Cyanidin chloride

    Cyanidin chloride

    Product Name:Cyanidin chloride
    Molecular Formula:C15H11ClO6
    Molecular Weight:322.7
    CAS Registry Number:528-58-5
  • 5-(4-Bromophenyl)-4,6-dichloropyrimidine

    5-(4-Bromophenyl)-4,6-dichloropyrimidine

    Product Name:5-(4-Bromophenyl)-4,6-dichloropyrimidine
    Molecular Formula:C10H5BrCl2N2
    Molecular Weight:303.97
    CAS Registry Number:146533-41-7
  • M-Toluic Acid

    M-Toluic Acid

    Product Name:M-Toluic Acid
    Molecular Weight:136.15
    CAS Registry Number:99-04-7
  • 3-CHLORO-4-FLUOROTOLUENE

    3-CHLORO-4-FLUOROTOLUENE

    Product Name:3-CHLORO-4-FLUOROTOLUENE
    Molecular Formula:C7H6ClF
    Molecular Weight:144.57
    CAS Registry Number:1513-25-3
  • Efavirenz

    Efavirenz

    Product Name:Efavirenz
    Molecular Formula:C14H9ClF3NO2
    Molecular Weight;315.67
    CAS Registry Number;154598-52-4
  • 2-Ethoxybenzamidine hydrochloride

    2-Ethoxybenzamidine hydrochloride

    Product Name:2-Ethoxybenzamidine hydrochloride
    Molecular Formula:C9H13ClN2O
    Molecular Weight:200.67
    CAS Registry Number:18637-00-8
  • Related Blog
  • Reviews

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

  • Caffeine CAS No.58-08-2

    Caffeine (CAS No.58-08-2) is a xanthine alkaloid compound, a central nervous stimulant that temporarily drives away drowsiness and restores energy, and is used clinically to treat neurosis and coma recovery. Caffeinated coffee, tea, soft drinks and energy drinks are very popular, so caffeine is also the most commonly used psychotropic drug in the world.

  • What is Coenzyme Q10 CAS NO.303-98-0

    Coenzyme Q10 (CAS NO.303-98-0 ) is a fat-soluble antioxidant, which can activate the nutrition of human cells and cellular energy, and has the functions of improving human immunity, enhancing antioxidation, delaying ageing and enhancing human vitality.

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept